Patent · US Expired

Androgen derivatives and uses thereof

US6916791B2 · kind B2 · utility

1Cited by
161References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2003
Grant dateJul 12, 2005
Priority date—
Expiry dateMay 30, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J71/0047
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Androgen glycosides provide free, circulatory androgen on oral administration as they are subject to less, first pass breakdown by the liver.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.